California-Based Multinational Biopharmaceutical Company
A large multinational biopharmaceutical company was unable to enter the Mexican market due to a regulation requiring a local manufacturing presence in order to sell pharmaceuticals. Further, Mexico lacked sufficient regulation for domestic production of biologic products and did not permit the import of these products.
We helped our client solve both hurdles by working with Mexican authorities, including the Ministry of Economy and COFEPRIS (FDA equivalent), to develop appropriate regulatory modifications. In tandem with providing advocacy services, we helped the company build its own in-house government relations capabilities.
Our client was able to register a number of its biologic products to successfully enter the Mexican market, and it remains an important participant in the Mexican healthcare market through provision of medications that improve the quality of life for Mexican patients and their families.
Mexican Medical Device Association
Mexico’s preeminent medical device association, in concert with its U.S.-based counterpart, sought to enhance awareness among key stakeholders of the industry’s contribution to Mexico’s economic development and the quality of life of its citizens. A senior-level member delegation to Mexico City provided a unique opportunity to implement a new, more active government relations strategy.
We developed an intensive schedule of high-level meetings with a range of government officials representing the ministries and agencies responsible for policies and regulation of direct relevance to the medical device industry. Our knowledge of the regulatory environment for devices and our ability to effectively reach into the Mexican Administration at the highest levels, preceded by delivery of extensive written and oral briefing materials, allowed the senior leadership of the association’s member companies to advocate for policy changes and promote awareness of the industry’s role in the Mexican economy and healthcare delivery infrastructure.
Our client and its members were able to deliver key messages to the appropriate policy makers and underscore the industry’s commitment to Mexico. Several of the officials with whom we met agreed to undertake follow up actions in conjunction with our client’s local company representatives as a result of these meetings. The device industry is now better positioned vis-à-vis the Peña Nieto Administration to achieve its policy advocacy objectives.
Mexico's Leading Pharmaceutical Research Association
Mexico’s leading pharmaceutical research association wanted to show that inadequate and inefficient healthcare spending, and the resulting limited access to innovative medicines, has a negative impact on industrial productivity and overall economic growth in Mexico.
We conducted an analysis of the impact of poor healthcare services on the productivity of the automotive sector in the state of Guanajuato. We then worked with the association on effective messaging of the study results and presented them to a wide range of public and private stakeholders at a series of events in Mexico City.
The report release was covered widely by Mexican media and the key messages were frequently emphasized. We anticipate that the automotive sector, which has been reluctant to share data, will provide additional information allowing us to improve the accuracy of the report (thus further reinforcing its messages).